(3R,4R,6R)-6-[(1R)-1-hydroxy-1-[(1S,3R,8S,9S,10R,13S,14S,17S)-1-hydroxy-10,13-dimethyl-3-[(2R,3R,4S,5S,6R)-3,4,5-trihydroxy-6-[[(2R,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxymethyl]oxan-2-yl]oxy-2,3,4,7,8,9,11,12,14,15,16,17-dodecahydro-1H-cyclopenta[a]phenanthren-17-yl]ethyl]-3,4-dimethyloxan-2-one
Internal ID | 28388515-f3ba-44d0-a914-24825a56208d |
Taxonomy | Lipids and lipid-like molecules > Steroids and steroid derivatives > Steroid lactones > Withanolides and derivatives > Withanolide glycosides and derivatives |
IUPAC Name | (3R,4R,6R)-6-[(1R)-1-hydroxy-1-[(1S,3R,8S,9S,10R,13S,14S,17S)-1-hydroxy-10,13-dimethyl-3-[(2R,3R,4S,5S,6R)-3,4,5-trihydroxy-6-[[(2R,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxymethyl]oxan-2-yl]oxy-2,3,4,7,8,9,11,12,14,15,16,17-dodecahydro-1H-cyclopenta[a]phenanthren-17-yl]ethyl]-3,4-dimethyloxan-2-one |
SMILES (Canonical) | CC1CC(OC(=O)C1C)C(C)(C2CCC3C2(CCC4C3CC=C5C4(C(CC(C5)OC6C(C(C(C(O6)COC7C(C(C(C(O7)CO)O)O)O)O)O)O)O)C)C)O |
SMILES (Isomeric) | C[C@@H]1C[C@@H](OC(=O)[C@@H]1C)[C@@](C)([C@H]2CC[C@@H]3[C@@]2(CC[C@H]4[C@H]3CC=C5[C@@]4([C@H](C[C@@H](C5)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO[C@H]7[C@@H]([C@H]([C@@H]([C@H](O7)CO)O)O)O)O)O)O)O)C)C)O |
InChI | InChI=1S/C40H64O15/c1-17-12-28(55-35(49)18(17)2)40(5,50)26-9-8-22-21-7-6-19-13-20(14-27(42)39(19,4)23(21)10-11-38(22,26)3)52-37-34(48)32(46)30(44)25(54-37)16-51-36-33(47)31(45)29(43)24(15-41)53-36/h6,17-18,20-34,36-37,41-48,50H,7-16H2,1-5H3/t17-,18-,20-,21+,22+,23+,24-,25-,26+,27+,28-,29-,30-,31+,32+,33-,34-,36-,37-,38+,39+,40-/m1/s1 |
InChI Key | UGBPBWCHBDJYOY-VTCUMTAISA-N |
Popularity | 0 references in papers |
Molecular Formula | C40H64O15 |
Molecular Weight | 784.90 g/mol |
Exact Mass | 784.42452133 g/mol |
Topological Polar Surface Area (TPSA) | 245.00 Ų |
XlogP | 0.80 |
There are no found synonyms. |
![2D Structure of (3R,4R,6R)-6-[(1R)-1-hydroxy-1-[(1S,3R,8S,9S,10R,13S,14S,17S)-1-hydroxy-10,13-dimethyl-3-[(2R,3R,4S,5S,6R)-3,4,5-trihydroxy-6-[[(2R,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxymethyl]oxan-2-yl]oxy-2,3,4,7,8,9,11,12,14,15,16,17-dodecahydro-1H-cyclopenta[a]phenanthren-17-yl]ethyl]-3,4-dimethyloxan-2-one 2D Structure of (3R,4R,6R)-6-[(1R)-1-hydroxy-1-[(1S,3R,8S,9S,10R,13S,14S,17S)-1-hydroxy-10,13-dimethyl-3-[(2R,3R,4S,5S,6R)-3,4,5-trihydroxy-6-[[(2R,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxymethyl]oxan-2-yl]oxy-2,3,4,7,8,9,11,12,14,15,16,17-dodecahydro-1H-cyclopenta[a]phenanthren-17-yl]ethyl]-3,4-dimethyloxan-2-one](https://plantaedb.com/storage/docs/compounds/2023/11/5f3aa100-858c-11ee-af44-bfba703ecf43.jpg)
Target | Value | Probability (raw) | Probability (%) |
---|---|---|---|
No predicted properties yet! |
Proven Targets:
CHEMBL ID | UniProt ID | Name | Min activity | Assay type | Source |
---|---|---|---|---|---|
No proven targets yet! |
Predicted Targets (via Super-PRED):
CHEMBL ID | UniProt ID | Name | Probability | Model accuracy |
---|---|---|---|---|
CHEMBL253 | P34972 | Cannabinoid CB2 receptor | 97.96% | 97.25% |
CHEMBL4261 | Q16665 | Hypoxia-inducible factor 1 alpha | 96.18% | 85.14% |
CHEMBL3251 | P19838 | Nuclear factor NF-kappa-B p105 subunit | 95.59% | 96.09% |
CHEMBL3137262 | O60341 | LSD1/CoREST complex | 94.82% | 97.09% |
CHEMBL5619 | P27695 | DNA-(apurinic or apyrimidinic site) lyase | 94.16% | 91.11% |
CHEMBL1871 | P10275 | Androgen Receptor | 93.96% | 96.43% |
CHEMBL1994 | P08235 | Mineralocorticoid receptor | 93.38% | 100.00% |
CHEMBL1293249 | Q13887 | Kruppel-like factor 5 | 92.45% | 86.33% |
CHEMBL1937 | Q92769 | Histone deacetylase 2 | 91.98% | 94.75% |
CHEMBL1806 | P11388 | DNA topoisomerase II alpha | 90.89% | 89.00% |
CHEMBL226 | P30542 | Adenosine A1 receptor | 89.75% | 95.93% |
CHEMBL3713062 | P10646 | Tissue factor pathway inhibitor | 89.12% | 97.33% |
CHEMBL3351 | Q13085 | Acetyl-CoA carboxylase 1 | 88.99% | 93.04% |
CHEMBL2635 | P51452 | Dual specificity protein phosphatase 3 | 88.18% | 94.00% |
CHEMBL4016 | P42262 | Glutamate receptor ionotropic, AMPA 2 | 87.37% | 86.92% |
CHEMBL5255 | O00206 | Toll-like receptor 4 | 86.72% | 92.50% |
CHEMBL3108638 | O15164 | Transcription intermediary factor 1-alpha | 86.11% | 95.56% |
CHEMBL1907603 | Q05586 | Glutamate NMDA receptor; GRIN1/GRIN2B | 84.02% | 95.89% |
CHEMBL4051 | P13569 | Cystic fibrosis transmembrane conductance regulator | 83.77% | 95.71% |
CHEMBL3401 | O75469 | Pregnane X receptor | 83.56% | 94.73% |
CHEMBL2581 | P07339 | Cathepsin D | 83.26% | 98.95% |
CHEMBL5608 | Q16288 | NT-3 growth factor receptor | 83.17% | 95.89% |
CHEMBL5103 | Q969S8 | Histone deacetylase 10 | 82.48% | 90.08% |
CHEMBL1951 | P21397 | Monoamine oxidase A | 82.24% | 91.49% |
CHEMBL4203 | Q9HAZ1 | Dual specificity protein kinase CLK4 | 81.86% | 94.45% |
CHEMBL5163 | Q9NY46 | Sodium channel protein type III alpha subunit | 81.82% | 96.90% |
CHEMBL5028 | O14672 | ADAM10 | 81.81% | 97.50% |
CHEMBL4478 | Q00975 | Voltage-gated N-type calcium channel alpha-1B subunit | 80.67% | 97.14% |
Below are displayed all the plants proven (via scientific papers) to contain this
compound!
To see more specific details click the taxa you are interested in.
To see more specific details click the taxa you are interested in.
Withania somnifera |
PubChem | 163006532 |
LOTUS | LTS0190239 |
wikiData | Q105272248 |